Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.Market Watch • 10/21/26
Moderna's Respiratory Portfolio Expands: Can It Reduce COVID Reliance?Zacks Investment Research • 10/21/26
Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026The Motley Fool • 10/21/26
Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking NoticeThe Motley Fool • 10/21/26
Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Inches Higher24/7 Wall Street • 10/20/26
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are WinningMarketBeat • 10/19/26
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady24/7 Wall Street • 10/16/26
Moderna Tumbles 10% as Profit Taking Hits Cancer Vaccine Rally; BioNTech Eases, Pfizer Stays Put24/7 Wall Street • 10/16/26
Meet the New Nasdaq-100 Stock That's Crushing Nvidia, Micron, and Sandisk. Is It Too Late to Buy?The Motley Fool • 10/16/26
Moderna: Best S&P 500 Stock YTD Could Rally Into YE, But Valuation Is UncertainSeeking Alpha • 10/15/26
Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher24/7 Wall Street • 10/15/26
Moderna Stock Is Soaring on Cancer Vaccine Buzz. Is It Too Late to Get In?24/7 Wall Street • 10/15/26
Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to makeCNBC • 10/14/26
Federal and state regulators asked a judge to hold “pharma bro” Martin Shkreli in contempt, alleging he traded drug stocks despite a lifetime ban from the pharmaceutical industryWSJ • 10/13/26
FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma banBusiness Insider • 10/13/26
‘Pharma Bro' Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocksMarket Watch • 10/13/26
Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 10/13/26
Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026Accesswire • 10/13/26